Pharmaceutical Giants: A Tale of Two Approaches The pharmaceutical industry often pits innovation against cost cutting.
Eli Lilly and Teva Pharmaceutical Industries represent two distinct strategies for achieving success.
While Eli Lilly focuses on developing high priced treatments protected by patents, Teva produces generics that make healthcare more affordable for millions. Eli Lilly's FY 2025 revenue reached $65.